Fast. Easy. Simple.
Flowflex SARS-CoV-2 Antigen Rapid Test is a lateral flow chromatographic immunoassay for the qualitative detection the nucleocapsid protein antigen from SARS-CoV-2 in nasal and nasopharyngeal swab specimens.
- Nasal and Nasopharyngeal swab specimens
- Results in 15 minutes
- Excellent performance compared to molecular methods
- Room temperature storage
The Flowflex SARS-CoV-2 Antigen Rapid Test is authorised for use in Singapore by the Health Science Authority (HSA) under the Pandemic Special Access Route (PSAR) and Pre-Market Approval (PMA). The test does not require skilled professional or equipment to interpret the test results. Suitable for home and office use.
About Flowflex™ SARS-CoV-2 Antigen Rapid Test
The FlowFlex has a sensitivity of 97.4% and specificity of 99.7% according to the Product Insert under the PMA granted by HSA. These have been supported by clinical studies. FindDx is a leading independent organization. Evaluation reports published by FindDx are available publicly and forms part of MOH’s evaluation criteria.
FindDx Evaluation report for the FlowFlex ART
FindDx Evaluation report for SD Biosensor Standard Q ART
FindDx Evaluation report for Abbott Panbio ART
Source: FindDx evaluation reports of SARS-CoV-2 ART
FindDx evaluation reports of SARS-CoV-2 ART On September 2021, the Flowflex became the second COVID-19 Antigen Rapid Test that been issued Pre Market Approval (PMA) after the SD Biosensor Standard Q. Since November 2021, the Flowflex has also approved under the PSAR.
University of Geneva evaluates several ARTs against Omicron and Delta variants
FlowFlex has a sensitivity of 91.2% against the Delta and 88.9% against the Omicron.
Standard Q has a sensitivity of 52.9% against the Delta and 22.2% against the Omicron.
Panbio has a sensitivity of 67.7% against the Delta and 36.1% against the Omicron.
Around the world
Self Testing in the USA
The FlowFlex ART has obtained FDA EUA in October 2021. Making it one of the few brands in the world with such an approval. With this approval, the FlowFlex is also available in the USA and several other markets that rely on FDA's evaluation of the ART.
Self testing in UK and across EU
U.K. Government validated at Public Health England, Porton Down Laboratories. Full Home Test Approval in the UK and EU. Achieved CE Mark for Self Testing by EU notify body.
Used by school children in Europe
FlowFlex have been the winner of prestigious tenders by Dutch MOH, German MOH, Austrian MOE (education), Czech MOE and Lithuania MOH. They have produced over 500M test kits since the outset of COVID 19.
Media Coverage
Partners
